Cargando…
MicroRNAs in CSF as prodromal biomarkers for Huntington disease in the PREDICT-HD study
OBJECTIVE: To investigate the feasibility of microRNA (miRNA) levels in CSF as biomarkers for prodromal Huntington disease (HD). METHODS: miRNA levels were measured in CSF from 60 PREDICT-HD study participants using the HTG protocol. Using a CAG–Age Product score, 30 prodromal HD participants were s...
Autores principales: | Reed, Eric R., Latourelle, Jeanne C., Bockholt, Jeremy H., Bregu, Joli, Smock, Justin, Paulsen, Jane S., Myers, Richard H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798654/ https://www.ncbi.nlm.nih.gov/pubmed/29282329 http://dx.doi.org/10.1212/WNL.0000000000004844 |
Ejemplares similares
-
Patterns of Co-Occurring Gray Matter Concentration Loss across the Huntington Disease Prodrome
por: Ciarochi, Jennifer Ashley, et al.
Publicado: (2016) -
Genetics Modulate Gray Matter Variation Beyond Disease Burden in Prodromal Huntington’s Disease
por: Liu, Jingyu, et al.
Publicado: (2018) -
Quality of Life in Prodromal HD: Qualitative Analyses of Discourse from Participants and Companions
por: Ready, Rebecca E., et al.
Publicado: (2011) -
RNA Sequence Analysis of Human Huntington Disease Brain Reveals an Extensive Increase in Inflammatory and Developmental Gene Expression
por: Labadorf, Adam, et al.
Publicado: (2015) -
Neuroanatomical correlates of cognitive functioning in prodromal Huntington disease
por: Harrington, Deborah L, et al.
Publicado: (2014)